Screener
Doximity DOCS Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Doximity in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: Doximity’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0001516513-26-000040
FAQ
- What is Doximity's cash & equivalents?
- Doximity (DOCS) reported cash & equivalents of $273.6M in Q2 2026.
- How has Doximity's cash & equivalents changed year-over-year?
- Doximity's cash & equivalents increased by 99.3% year-over-year, from $137.26M to $273.6M.
- What is the long-term trend for Doximity's cash & equivalents?
- Over 5 years (2021 to 2026), Doximity's cash & equivalents has grown at a 27.0% compound annual growth rate (CAGR), from $66.39M to $219.18M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Doximity's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude